Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion
ABSTRACT Objective: To evaluate the safety and feasibility of the use of indwelling pleural catheters (IPCs) in patients with malignant pleural effusion (MPE). Methods: We prospectively collected data from patients with MPE undergoing IPC placement between January of 2014 and July of 2015. All p...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Pneumologia e Tisiologia
|
| Series: | Jornal Brasileiro de Pneumologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017005001104&lng=en&tlng=en |
| _version_ | 1818451426941075456 |
|---|---|
| author | Fernando Conrado Abrão Igor Renato Louro Bruno de Abreu Maria Gabriela Cavalcanti José Franklin Soares Pompa-Filho |
| author_facet | Fernando Conrado Abrão Igor Renato Louro Bruno de Abreu Maria Gabriela Cavalcanti José Franklin Soares Pompa-Filho |
| author_sort | Fernando Conrado Abrão |
| collection | DOAJ |
| description | ABSTRACT Objective: To evaluate the safety and feasibility of the use of indwelling pleural catheters (IPCs) in patients with malignant pleural effusion (MPE). Methods: We prospectively collected data from patients with MPE undergoing IPC placement between January of 2014 and July of 2015. All patients submitted to IPC placement had a life expectancy > 30 days, in accordance with the MPE treatment guidelines established by the British Thoracic Society. The data collected included gender, age, body mass index, primary cancer site, duration of IPC drainage, IPC-related complications, length of hospital stay, pleural effusion recurrence, and occurrence of spontaneous pleurodesis. Results: A total of 19 patients underwent IPC placement during the study period. Median overall survival after IPC insertion was 145 days. The median follow-up among the surviving patients was 125 days (range, 53-485 days), and the median time between catheter insertion and removal was 31 days (range, 2-126 days). There were IPC-related complications in 5 patients (26.2%), and spontaneous pleurodesis was achieved in 8 (42.0%). Among those 8 patients, the IPC was removed between days 30 and 126 in 4, and spontaneous pleurodesis occurred within the first 30 days in 4. Conclusions: The use of IPCs seems to be feasible and safe in patients with MPE. |
| first_indexed | 2024-12-14T21:07:01Z |
| format | Article |
| id | doaj.art-35f6a031afbd4f818d9c0beb22487894 |
| institution | Directory Open Access Journal |
| issn | 1806-3756 |
| language | English |
| last_indexed | 2024-12-14T21:07:01Z |
| publisher | Sociedade Brasileira de Pneumologia e Tisiologia |
| record_format | Article |
| series | Jornal Brasileiro de Pneumologia |
| spelling | doaj.art-35f6a031afbd4f818d9c0beb224878942022-12-21T22:47:23ZengSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia1806-3756010.1590/s1806-37562016000000021S1806-37132017005001104Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusionFernando Conrado AbrãoIgor Renato Louro Bruno de AbreuMaria Gabriela CavalcantiJosé Franklin Soares Pompa-FilhoABSTRACT Objective: To evaluate the safety and feasibility of the use of indwelling pleural catheters (IPCs) in patients with malignant pleural effusion (MPE). Methods: We prospectively collected data from patients with MPE undergoing IPC placement between January of 2014 and July of 2015. All patients submitted to IPC placement had a life expectancy > 30 days, in accordance with the MPE treatment guidelines established by the British Thoracic Society. The data collected included gender, age, body mass index, primary cancer site, duration of IPC drainage, IPC-related complications, length of hospital stay, pleural effusion recurrence, and occurrence of spontaneous pleurodesis. Results: A total of 19 patients underwent IPC placement during the study period. Median overall survival after IPC insertion was 145 days. The median follow-up among the surviving patients was 125 days (range, 53-485 days), and the median time between catheter insertion and removal was 31 days (range, 2-126 days). There were IPC-related complications in 5 patients (26.2%), and spontaneous pleurodesis was achieved in 8 (42.0%). Among those 8 patients, the IPC was removed between days 30 and 126 in 4, and spontaneous pleurodesis occurred within the first 30 days in 4. Conclusions: The use of IPCs seems to be feasible and safe in patients with MPE.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017005001104&lng=en&tlng=enDerrame pleural malignoSobrevivênciaCuidados paliativos |
| spellingShingle | Fernando Conrado Abrão Igor Renato Louro Bruno de Abreu Maria Gabriela Cavalcanti José Franklin Soares Pompa-Filho Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion Jornal Brasileiro de Pneumologia Derrame pleural maligno Sobrevivência Cuidados paliativos |
| title | Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion |
| title_full | Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion |
| title_fullStr | Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion |
| title_full_unstemmed | Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion |
| title_short | Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion |
| title_sort | use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion |
| topic | Derrame pleural maligno Sobrevivência Cuidados paliativos |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017005001104&lng=en&tlng=en |
| work_keys_str_mv | AT fernandoconradoabrao useofindwellingpleuralcathetersforthedefinitivetreatmentofmalignantpleuraleffusion AT igorrenatolourobrunodeabreu useofindwellingpleuralcathetersforthedefinitivetreatmentofmalignantpleuraleffusion AT mariagabrielacavalcanti useofindwellingpleuralcathetersforthedefinitivetreatmentofmalignantpleuraleffusion AT josefranklinsoarespompafilho useofindwellingpleuralcathetersforthedefinitivetreatmentofmalignantpleuraleffusion |